Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2020

01-12-2020 | Knee Osteoarthritis | Letter

Response to “Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study”

Authors: Jean-Pierre Pelletier, Jean-Pierre Raynauld

Published in: Arthritis Research & Therapy | Issue 1/2020

Login to get access

Excerpt

In the last issue of Arthritis Research & Therapy, Henrotin et al. [1] report the outcomes of a double-blind multicenter randomized placebo controlled, three-arm study assessing the effect of two doses of bio-optimised Curcuma longa (BCL) on the symptoms of knee osteoarthritis (OA). They conclude in the “key messages” that BCL is an efficient and safe treatment to relieve pain in knee OA patients. …
Literature
1.
Metadata
Title
Response to “Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study”
Authors
Jean-Pierre Pelletier
Jean-Pierre Raynauld
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2020
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-020-2108-3

Other articles of this Issue 1/2020

Arthritis Research & Therapy 1/2020 Go to the issue

Research article

Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates

Research article

Magnetic resonance imaging compared to ultrasonography in giant cell arteritis: a cross-sectional study

Research article

Obstructive sleep apnea and the risk of gout: a population-based case-control study

Review

Post-traumatic osteoarthritis following ACL injury

Research article

Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials

Research article

IgG subclasses in cryoglobulins: link to composition and clinical manifestations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits